1
Bender Steven Lee, Bhumralkar Dilip, Collins Michael Raymond, Cripps Stephan James, Deal Judith Gail, Nambu Mitchell David, Palmer Cynthia Louise, Peng Zhengwei, Varney Michael David, Jia Lei: Amide compounds for inhibiting protein kinases. Agouron Pharmaceuticals, GADIANO Christina, July 26, 2001: WO/2001/053274 (2 worldwide citation)

Amide compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/or inhibit unwanted cell proliferation. The invent ...


2
Chong Wesley Kwan Mung, Duvadie Rohit Kumar: Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases. Agouron Pharmaceuticals, GADIANO Christina M, February 14, 2002: WO/2002/012250

Pyrazole-thiazole compounds that modulate and/or inhibit the activity of cyclin-dependent kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating cyclin-dependent diseases to modulate and/or inhibit unwanted cell proliferation. The invention is ...


3
Chong Wesley Kwan Mung, Duvadie Rohit Kumar: Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases. Agouron Pharmaceuticals, GADIANO Christina M, February 28, 2002: WO/2002/016326

Compunds of the formula I or II wherein X is CY or N, and W is O or S, modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/ ...


4
Abreo Melwyn A, Meng Jerry J, Agree Charles Scott: Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity. Agouron Pharmaceuticals, GADIANO Christina M, February 28, 2002: WO/2002/016365

Pyrazole compounds represented by the formula (I), are described. The pyrazole compounds and pharmaceutical compositions containing them may be used in inhibiting ERAB or HADH2 activity and in treating ERAB, HADH2 or amyloid-$g(b) mediated diseases and conditions.


5
Reich Siegfried Heinz, Wallace Michael B: Pyrazoles for inhibiting protein kinase. Agouron Pharmaceuticals, GADIANO Christina M, October 25, 2001: WO/2001/079198

Amino-pyrazole compounds of formula (I), that modulate and/or inhibit the activity of protein kinases. These compounds and pharmaceutical compositions containing them are capable of mediating and/or inhibiting the activity cyclin-dependent kinases, thereby modulating and/or inhibiting unwanted cell ...